Abstract
There are fetal sex-specific differences in the balance between angiotensin (Ang) II and Ang-(1–7) in the maternal circulation during pregnancy. To determine whether at 15 weeks’ gestation plasma levels of Ang II and Ang-(1–7), as well as levels of prorenin and Ang-converting enzyme (ACE), predicted the development of gestational hypertension (GH) or preeclampsia (PreE) and were associated with estimates of fetal and maternal health, women who later developed GH (n=50) or PreE (n=50) were compared with body mass index-matched controls (n=100). Women who subsequently developed PreE or GH had increased Ang-(1–7) levels at 15 weeks’ gestation compared with women with normal pregnancies. When separated by fetal sex, this difference was seen only in women carrying a female fetus. Prorenin and ACE concentrations were not useful biomarkers for the prediction of either PreE or GH at 15 weeks’ gestation. Women with a male fetus who developed PreE and women who subsequently developed GH had increased blood pressures at 15 weeks’ gestation compared with women with normal pregnancies, suggesting that these women were on an early trajectory for the development of hypertension. We propose that measurement of Ang-(1–7) during early gestation could be useful in predicting, those women who will go on to develop new-onset hypertension in pregnancy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF . WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367 (9516): 1066–1074.
Duley L . The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33 (3): 130–137.
Danser AH, Derkx FH, Schalekamp MA, Hense HW, Riegger GA, Schunkert H . Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens 1998; 16 (6): 853–862.
Gilbert JS, Nijland MJ . Sex differences in the developmental origins of hypertension and cardiorenal disease. Am J Physiol Regul Integr Comp Physiol 2008; 295 (6): R1941–R1952.
Bachmann J, Feldmer M, Ganten U, Stock G, Ganten D . Sexual dimorphism of blood pressure: possible role of the renin-angiotensin system. J Steroid Biochem Mol Biol 1991; 40 (4-6): 511–515.
Clauser E, Gaillard I, Wei L, Corvol P . Regulation of angiotensinogen gene. Am JHypertens 1989; 2 (5 Pt 1): 403–410.
Sykes SD, Pringle KG, Zhou A, Dekker GA, Roberts CT, Lumbers ER . The balance between human maternal plasma angiotensin II and angiotensin 1-7 levels in early gestation pregnancy is influenced by fetal sex. J Renin Angiotensin Aldosterone Syst 2013 (e-pub ahead of print, 27 February 2013; doi:2010.1177/1470320313477174).
Roberts JM, Escudero C . The placenta in preeclampsia. Pregnancy Hypertens 2012; 2 (2): 72–83.
Anton L, Merrill DC, Neves LA, Gruver C, Moorefield C, Brosnihan KB . Angiotensin II and angiotensin-(1-7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: an in vitro study. Reprod Biol Endocrinol 2010; 8: 135.
North RA, McCowan LM, Dekker GA, Poston L, Chan EH, Stewart AW et al. Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort. BMJ 2011; 342: d1875.
Hanssens M, Keirse MJ, Spitz B, van Assche FA . Angiotensin II levels in hypertensive and normotensive pregnancies. Br J Obstet Gynaecol 1991; 98 (2): 155–161.
Nogueira AI, Souza Santos RA, Simoes ESAC, Cabral AC, Vieira RL, Drumond TC et al. The pregnancy-induced increase of plasma angiotensin-(1-7) is blunted in gestational diabetes. Regul Pept 2007; 141 (1-3): 55–60.
Baker PN, Broughton Pipkin F, Symonds EM . Platelet angiotensin II binding and plasma renin concentration, plasma renin substrate and plasma angiotensin II in human pregnancy. Clin Sci (Lond) 1990; 79 (4): 403–408.
Langer B, Grima M, Coquard C, Bader AM, Schlaeder G, Imbs JL . Plasma active renin, angiotensin I, and angiotensin II during pregnancy and in preeclampsia. Obstet Gynecol 1998; 91 (2): 196–202.
Merrill DC, Karoly M, Chen K, Ferrario CM, Brosnihan KB . Angiotensin-(1-7) in normal and preeclamptic pregnancy. Endocrine 2002; 18 (3): 239–245.
Symonds EM, Broughton Pipkin F, Craven DJ . Changes in the renin-angiotensin system in primigravidae with hypertensive disease of pregnancy. Br J Obstet Gynaecol 1975; 82 (8): 643–650.
Velloso EP, Vieira R, Cabral AC, Kalapothakis E, Santos RA . Reduced plasma levels of angiotensin-(1-7) and renin activity in preeclamptic patients are associated with the angiotensin I- converting enzyme deletion/deletion genotype. Braz J Med Biol Res 2007; 40 (4): 583–590.
Marques FZ, Pringle KG, Conquest A, Hirst JJ, Markus MA, Sarris M et al. Molecular characterization of renin-angiotensin system components in human intrauterine tissues and fetal membranes from vaginal delivery and cesarean section. Placenta 2011; 32 (3): 214–221.
Pringle KG, Tadros MA, Callister RJ, Lumbers ER . The expression and localization of the human placental prorenin/renin-angiotensin system throughout pregnancy: roles in trophoblast invasion and angiogenesis? Placenta 2011; 32 (12): 956–962.
Valdes G, Neves LA, Anton L, Corthorn J, Chacon C, Germain AM et al. Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies. Placenta 2006; 27 (2-3): 200–207.
Khong TY, De Wolf F, Robertson WB, Brosens I . Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986; 93 (10): 1049–1059.
Simmons LA, Hennessy A, Gillin AG, Jeremy RW . Uteroplacental blood flow and placental vascular endothelial growth factor in normotensive and pre-eclamptic pregnancy. BJOG 2000; 107 (5): 678–685.
Laresgoiti-Servitje E, Gomez-Lopez N . The pathophysiology of preeclampsia involves altered levels of angiogenic factors promoted by hypoxia and autoantibody-mediated mechanisms. Biol Reprod 2012; 87 (2): 36.
Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jupner A et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 1999; 103 (7): 945–952.
Siddiqui AH, Irani RA, Blackwell SC, Ramin SM, Kellems RE, Xia Y . Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity. Hypertension 2010; 55 (2): 386–393.
Dechend R, Muller DN, Wallukat G, Homuth V, Krause M, Dudenhausen J et al. Activating auto-antibodies against the AT1 receptor in preeclampsia. Autoimmun Rev 2005; 4 (1): 61–65.
Kooner JS, May CN, Peart S, Mathias CJ . Separation of peripheral and central cardiovascular actions of angiotensin II. Am J Physiol 1997; 273 (6 Pt 2): H2620–H2626.
Smookler HH, Severs WB, Kinnard WJ, Buckley JP . Centrally mediated cardiovascular effects of angiotensin II. J Pharmacol Exp Ther 1966; 153 (3): 485–494.
Heitsch H, Brovkovych S, Malinski T, Wiemer G . Angiotensin-(1-7)-stimulated nitric oxide and superoxide release from endothelial cells. Hypertension 2001; 37 (1): 72–76.
Silvestre JS, Levy BI . [The renin-angiotensin system and post-ischemic angiogenesis]. Bull Acad Natl Med 2004; 188 (4): 649–659 discussion 659.
Carbajo-Lozoya J, Lutz S, Feng Y, Kroll J, Hammes HP, Wieland T . Angiotensin II modulates VEGF-driven angiogenesis by opposing effects of type 1 and type 2 receptor stimulation in the microvascular endothelium. Cell Signal 2012; 24 (6): 1261–1269.
Machado RD, Santos RA, Andrade SP . Mechanisms of angiotensin-(1-7)-induced inhibition of angiogenesis. Am J Physiol Regul Integr Comp Physiol 2001; 280 (4): R994–R1000.
Anton L, Merrill DC, Neves LA, Brosnihan KB . Angiotensin-(1-7) inhibits in vitro endothelial cell tube formation in human umbilical vein endothelial cells through the AT(1-7) receptor. Endocrine 2007; 32 (2): 212–218.
Soto-Pantoja DR, Menon J, Gallagher PE, Tallant EA . Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor. Mol Cancer Ther 2009; 8 (6): 1676–1683.
Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 2002; 277 (17): 14838–14843.
Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12 (6): 642–649.
McKeeman GC, Ardill JE, Caldwell CM, Hunter AJ, McClure N . Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obst Gynecol 2004; 191 (4): 1240–1246.
Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM . C-reactive protein and the risk of developing hypertension. JAMA 2003; 290 (22): 2945–2951.
Jasovic-Siveska E, Jasovic V . Prediction of mild and severe preeclampsia with blood pressure measurements in first and second trimester of pregnancy. Ginekol Pol 2011; 82 (11): 845–850.
Piquilloud Y, Reinharz A, Roth M . Studies on the angiotensin converting enzyme with different substrates. Biochim Biophys Acta 1970; 206 (1): 136–142.
Acknowledgements
This work was conducted using samples collected in Adelaide, Australia, by the SCOPE consortium. We thank the families who participated in the SCOPE study and Denise Healy for coordinating the Adelaide cohort. We also thank MedSciNet (Sweden), Eliza Chan and SCOPE midwives for their support with the database. The Australian SCOPE study was funded by the Premier's Science and Research Fund, Government of South Australia. Data analyses were funded by National Health and Medical Research Council Australia (NHMRC) Project Grant 565320 awarded to CTR and ERL and by the University of Adelaide. CTR is supported by NHMRC Senior Research Fellowship APP1020749.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Sykes, S., Pringle, K., Zhou, A. et al. Fetal sex and the circulating renin–angiotensin system during early gestation in women who later develop preeclampsia or gestational hypertension. J Hum Hypertens 28, 133–139 (2014). https://doi.org/10.1038/jhh.2013.51
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2013.51
Keywords
This article is cited by
-
Plasma and serum prorenin concentrations in diabetes, hypertension, and renal disease
Hypertension Research (2022)
-
Circulating prorenin: its molecular forms and plasma concentrations
Hypertension Research (2021)
-
Fetal sex and maternal pregnancy outcomes: a systematic review and meta-analysis
Biology of Sex Differences (2020)
-
Novel sex-specific influence of parental factors on small-for-gestational-age newborns
Scientific Reports (2020)
-
Differences in pregnancy complications and outcomes by fetal gender among Japanese women: a multicenter cross-sectional study
Scientific Reports (2020)